hVIVO #HVO – Result of AGM May 13, 2026 – Posted in: hVIVO (HVO) – Tags: hVIVO, HVO
London, UK – 13 May 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces that all resolutions put to shareholders at the Company’s Annual General Meeting (‘AGM’) held earlier today were duly passed.
The voting results of the AGM will be published on the Company website shortly: https://hvivo.com/company-documents/
For further information please contact:
|
hVIVO plc |
+44 (0)20 7756 1300 |
|||
|
Yamin ‘Mo’ Khan, Chief Executive Officer Stephen Pinkerton, Chief Financial Officer |
||||
|
Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) |
+44 (0)20 7220 0500 |
|||
|
Geoff Nash, Callum Davidson Nigel Birks – Life Science Specialist Sales Louise Talbot – Sales |
||||
|
Peel Hunt LLP (Joint Broker) |
+44 (0)20 7418 8900 |
|||
|
James Steel, Dr Christopher Golden |
||||
|
Davy (Joint Broker) |
+353 (0) 1 679 6363 |
|||
|
Anthony Farrell, Niall Gilchrist |
||||
|
ICR Healthcare (Financial PR & IR) Mary-Jane Elliott / Stephanie Cuthbert / Phillip Marriage / Louis Ashe-Jepson
|
hVIVO@icrhealthcare.com |
|||